{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:16Z","timestamp":1792801996942,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.bone.2017.01.023","type":"journal-article","created":{"date-parts":[[2017,1,22]],"date-time":"2017-01-22T08:47:40Z","timestamp":1485074860000},"page":"80-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":176,"special_numbering":"C","title":["The chronic kidney disease \u2014 Mineral bone disorder (CKD-MBD): Advances in pathophysiology"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4334-9099","authenticated-orcid":false,"given":"Keith A.","family":"Hruska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Sugatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Agapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9888","key":"10.1016\/j.bone.2017.01.023_bb0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.bone.2017.01.023_bb0010","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2017.01.023_bb0015","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bone.2017.01.023_bb0020","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2017.01.023_bb0025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","article-title":"Chronic kidney disease as cause of cardiovascular morbidity and mortality","volume":"20","author":"Vanholder","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.bone.2017.01.023_bb0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/j.ajkd.2014.08.001","article-title":"Diabetic kidney disease: a report from an ADA consensus conference","volume":"64","author":"Tuttle","year":"2014","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.bone.2017.01.023_bb0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2014.296","article-title":"Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes","volume":"87","author":"Papademetriou","year":"2015","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.bone.2017.01.023_bb0040","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.bone.2017.01.023_bb0045","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2017.01.023_bb0050","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.bone.2017.01.023_bb0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bone.2017.01.023_bb0060","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.bone.2017.01.023_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1681\/ASN.2014020173","article-title":"Subclinical atherosclerosis measures for cardiovascular prediction in CKD","volume":"26","author":"Matsushita","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.bone.2017.01.023_bb0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1530\/EJE-11-0577","article-title":"Relationship of serum fibroblast growth factor 23 with cardiovascular disease in older community-dwelling women","volume":"165","author":"Dalal","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2017.01.023_bb0075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0080","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1 and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.01.023_bb0085","first-page":"36A","article-title":"Early chronic kidney disease (CKD) stimulates vascular calcification (VC) and decreased bone formation rates prior to positive phosphate balance","volume":"20","author":"Fang","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2017.01.023_bb0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.bone.2017.01.023_bb0095","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","article-title":"CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder","volume":"25","author":"Fang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.bone.2017.01.023_bb0100","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/ndt\/gft234","article-title":"Disturbances of Wnt\/\u03b2-catenin pathway and energy metabolism in early CKD: effect of phosphate binders","volume":"28","author":"de Oliveira","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.bone.2017.01.023_bb0105","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.01.023_bb0110","doi-asserted-by":"crossref","first-page":"F431","DOI":"10.1152\/ajprenal.0009.2001","article-title":"A role for Wnt-4 in renal fibrosis","volume":"282","author":"Surendran","year":"2002","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bone.2017.01.023_bb0115","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1681\/ASN.2004110949","article-title":"Wnt-dependent-\u03b2-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis","volume":"16","author":"Surendran","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.bone.2017.01.023_bb0120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1359-6101(01)00010-7","article-title":"The role of the activin-follistatin system in the developmental and regeneration processes of the kidney","volume":"12","author":"Maeshima","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bone.2017.01.023_bb0125","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/01.ASN.0000060577.94532.06","article-title":"Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats","volume":"14","author":"Terada","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bone.2017.01.023_bb0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/path.4121","article-title":"Wnt signalling in kidney diseases: dual roles in renal injury and repair","volume":"229","author":"Kawakami","year":"2013","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.bone.2017.01.023_bb0135","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.celrep.2014.04.018","article-title":"In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration","volume":"7","author":"Rinkevich","year":"2014","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.bone.2017.01.023_bb0140","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.0912228107","article-title":"Macrophage Wnt7b is critical for kidney repair and regeneration","volume":"107","author":"Lin","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bone.2017.01.023_bb0145","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1038\/sj.onc.1207892","article-title":"DKK1, a negative regulator of Wnt signaling, is a target of the \u00e1-catenin\/TCF pathway","volume":"23","author":"Niida","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2017.01.023_bb0150","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","article-title":"Function and biological roles of the Dickkopf family of Wnt modulators","volume":"25","author":"Niehrs","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2017.01.023_bb0155","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature01593","article-title":"A role for Wnt signalling in self-renewal of haematopoietic stem cells","volume":"423","author":"Reya","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bone.2017.01.023_bb0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.emboj.7600460","article-title":"FGF-20 and DKK1 are transcriptional targets of \u03b2-catenin and FGF-20 is implicated in cancer and development","volume":"24","author":"Chamorro","year":"2004","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0165","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/sj.onc.1208303","article-title":"The Wnt antagonist DICKKOPF-1 gene is a downstream target of [beta]-catenin\/\/TCF and is downregulated in human colon cancer","volume":"24","author":"Gonzalez-Sancho","year":"2004","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bone.2017.01.023_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ydbio.2011.02.019","article-title":"Secreted Wnt antagonist Dickkopf-1 controls kidney papilla development coordinated by Wnt-7b signalling","volume":"353","author":"Pietil\u00e4","year":"2011","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bone.2017.01.023_bb0175","first-page":"245A","article-title":"A putative Wnt antagonist secreted frizzled-related protein 4 (sFRP4) suppresses the progression of renal fibrosis following unilateral ureteral obstruction","volume":"15","author":"Surendran","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"57","key":"10.1016\/j.bone.2017.01.023_bb0180","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","article-title":"Function and biological roles of the Dickkopf family of Wnt modulators","volume":"25","author":"Niehrs","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2017.01.023_bb0185","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2012050512","article-title":"Wnt4\/\u03b2\u2212Catenin signaling in medullary kidney myofibroblasts","author":"DiRocco","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.bone.2017.01.023_bb0190","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1073\/pnas.1211179110","article-title":"LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1","volume":"110","author":"Ren","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bone.2017.01.023_bb0195","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1681\/ASN.2008060566","article-title":"Wnt\/{beta}-catenin signaling promotes renal interstitial fibrosis","volume":"20","author":"He","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2017.01.023_bb0200","doi-asserted-by":"crossref","unstructured":"Evenepoel P, D'Haese P, Brandenburg V. Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int. 88(2):235\u2013240.","DOI":"10.1038\/ki.2015.156"},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0205","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness","volume":"90","author":"Thambiah","year":"2012","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.bone.2017.01.023_bb0210","first-page":"1","article-title":"Role of sclerostin in the pathogenesis of chronic kidney disease-mineral bone disorder","volume":"2","author":"Asamiya","year":"2016","journal-title":"Adv. Ren. Replace. Ther."},{"key":"10.1016\/j.bone.2017.01.023_bb0215","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res."},{"key":"10.1016\/j.bone.2017.01.023_bb0220","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","author":"Brunkow","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.bone.2017.01.023_bb0225","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","article-title":"A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population","volume":"110","author":"Staehling-Hampton","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bone.2017.01.023_bb0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J. Med. Genet."},{"issue":"3","key":"10.1016\/j.bone.2017.01.023_bb0235","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jbmr.2381","article-title":"HDAC5 controls MEF2C-driven sclerostin expression in osteocytes","volume":"30","author":"Wein","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.01.023_bb0240","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2017.01.023_bb0245","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bone.2017.01.023_bb0250","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2017.01.023_bb0255","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.01.023_bb0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","article-title":"Sclerostin: current knowledge and future perspectives","volume":"87","author":"Moester","year":"2011","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.bone.2017.01.023_bb0265","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2013-2786","article-title":"Renal elimination of sclerostin increases with declining kidney function","volume":"99","author":"Cejka","year":"2014","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.bone.2017.01.023_bb0270","doi-asserted-by":"crossref","unstructured":"Vervloet MG, Massy ZA, Brandenburg VM, et al. Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. Lancet Diabetes Endocrinol. 2(5):427\u2013436.","DOI":"10.1016\/S2213-8587(14)70059-2"},{"issue":"5","key":"10.1016\/j.bone.2017.01.023_bb0275","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.bone.2017.01.023_bb0280","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.bone.2017.01.023_bb0285","doi-asserted-by":"crossref","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","article-title":"Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients","volume":"99","author":"Kanbay","year":"2014","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.bone.2017.01.023_bb0290","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.2372","article-title":"Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy","volume":"30","author":"Moe","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2017.01.023_bb0295","first-page":"70","article-title":"New paradigm for progression of diabetic nephropathy","volume":"27","author":"Lee","year":"2013","journal-title":"Acta Nephrologica."},{"key":"10.1016\/j.bone.2017.01.023_bb0300","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/ATVBAHA.107.153668","article-title":"Aortic Msx2-Wnt calcification cascade is regulated by TNF-{alpha} dependent signals in diabetic Ldlr\/mice","volume":"27","author":"Al-Aly","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bone.2017.01.023_bb0305","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1172\/JCI24140","article-title":"Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals","volume":"115","author":"Shao","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bone.2017.01.023_bb0310","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/ATVBAHA.113.300647","article-title":"Dkk1 and Msx2\u2013Wnt7b signaling reciprocally regulate the endothelial\u2013mesenchymal transition in aortic endothelial cells","volume":"33","author":"Cheng","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bone.2017.01.023_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.77.1.1","article-title":"Molecular regulation of atrioventricular valvuloseptal morphogenesis","volume":"77","author":"Eisenberg","year":"1995","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bone.2017.01.023_bb0320","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/dbio.2002.0731","article-title":"Temporal and distinct TGF\u03b2 ligand requirements during mouse and avian endocardial cushion morphogenesis","volume":"248","author":"Camenisch","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bone.2017.01.023_bb0325","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bone.2017.01.023_bb0330","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload\u2013induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"227","key":"10.1016\/j.bone.2017.01.023_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006927","article-title":"TGF-\u03b2 signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling","volume":"6","author":"Cooley","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.bone.2017.01.023_bb0340","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/edrv-9-2-267","article-title":"Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone","volume":"9","author":"Ying","year":"1988","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0345","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.kint.2016.02.002","article-title":"Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease","volume":"89","author":"Agapova","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2017.01.023_bb0350","article-title":"A ligand of the activin receptor type IIA mediates osteoclast stimulation of bone remodeling in diabetic mice with CKD","author":"Toshifumi Sugatani","year":"2016","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.bone.2017.01.023_bb0355","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cvr\/cvs126","article-title":"Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study","volume":"94","author":"Naik","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bone.2017.01.023_bb0360","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1681\/ASN.2007121312","article-title":"CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas","volume":"20","author":"Kokubo","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2017.01.023_bb0365","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.100.21.2168","article-title":"Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification","volume":"100","author":"Shanahan","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2017.01.023_bb0370","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/CIRCRESAHA.108.183053","article-title":"Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries","volume":"104","author":"Speer","year":"2009","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bone.2017.01.023_bb0375","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jcmm.12373","article-title":"BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway","volume":"19","author":"Zhu","year":"2015","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.bone.2017.01.023_bb0380","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000353569","article-title":"Effects of phosphate binder therapy on vascular stiffness in the early chronic kidney disease","volume":"38","author":"Seifert","year":"2013","journal-title":"Am. J. Nephrol."},{"issue":"10","key":"10.1016\/j.bone.2017.01.023_bb0385","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by Klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.01.023_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2016.04.009","article-title":"In vivo evidence for a limited role of proximal tubular Klotho in renal phosphate handling","volume":"90","author":"Ide","year":"2016","journal-title":"Kidney Int."},{"issue":"50","key":"10.1016\/j.bone.2017.01.023_bb0395","doi-asserted-by":"crossref","first-page":"19796","DOI":"10.1073\/pnas.0709805104","article-title":"Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17","volume":"104","author":"Chen","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bone.2017.01.023_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086301","article-title":"Reduced renal \u03b1-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism","volume":"9","author":"Sakan","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bone.2017.01.023_bb0405","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1172\/JCI64986","article-title":"Circulating \u03b1Klotho influences phosphate handling by controlling FGF23 production","volume":"122","author":"Smith","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bone.2017.01.023_bb0410","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2010.328","article-title":"Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective","volume":"78","author":"Hu","year":"2010","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.bone.2017.01.023_bb0415","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0420","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0425","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2014050465","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling","volume":"26","author":"Hu","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.bone.2017.01.023_bb0430","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/ndt\/gfs050","article-title":"FGF23 and PTH\u2014double agents at the heart of CKD","volume":"27","author":"Silver","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.bone.2017.01.023_bb0435","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1681\/ASN.2004100835","article-title":"Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome","volume":"16","author":"Davies","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0440","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1681\/ASN.2007070760","article-title":"The mechanism of phosphorus as a cardiovascular risk factor in chronic kidney disease","volume":"19","author":"Mathew","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2017.01.023_bb0445","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.bone.2017.01.023_bb0450","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.273.9.5253","article-title":"RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate","volume":"273","author":"Moallem","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0455","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2017.01.023_bb0460","first-page":"P45A","article-title":"Effects of dietary phosphate restriction and lanthanum carbonate on FGF23 in CKD","volume":"23","author":"Isakova","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.bone.2017.01.023_bb0465","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrneph.2013.198","article-title":"Evaluating bone quality in patients with chronic kidney disease","volume":"9","author":"Malluche","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.bone.2017.01.023_bb0470","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2003.12.004","article-title":"Osteoporosis in chronic kidney disease","volume":"43","author":"Cunningham","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.bone.2017.01.023_bb0475","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0480","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.bone.2017.01.023_bb0485","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","volume":"26","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.01.023_bb0490","doi-asserted-by":"crossref","first-page":"E1636","DOI":"10.1152\/ajpendo.00396.2007","article-title":"Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice","volume":"293","author":"Liu","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bone.2017.01.023_bb0495","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2017.01.023_bb0500","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.bone.2017.01.023_bb0505","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the mild to moderate kidney disease (MMKD) study","volume":"18","author":"Fliser","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0510","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.bone.2017.01.023_bb0515","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.ajkd.2014.07.022","article-title":"Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade","volume":"65","author":"Humalda","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2017.01.023_bb0520","article-title":"FGF23 promotes renal calcium reabsorption through the TRPV5 channel","volume":"33","author":"Andrukhova","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2017.01.023_bb0525","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.1114245","article-title":"The \u00e1-glucuronidase klotho hydrolyzes and activates the TRPV5 channel","volume":"310","author":"Chang","year":"2005","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bone.2017.01.023_bb0530","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2215\/CJN.02680310","article-title":"Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23\/klotho system","volume":"5","author":"Pri\u00e9","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"S113","key":"10.1016\/j.bone.2017.01.023_bb0535","first-page":"S50","article-title":"Prevention, and treatment of the CKD-MBD. Chapter 4.1: Treatment of CKD-MBD targeted at lowering high serum phosphorus and maintaining serum calcium","volume":"76","author":"KDIGO Clinical Practice Guideline for the Diagnosis E","year":"2009","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0540","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI114931","article-title":"Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo","volume":"86","author":"Naveh-Many","year":"1990","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bone.2017.01.023_bb0545","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription","volume":"86","author":"Meir","year":"2014","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bone.2017.01.023_bb0550","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.semnephrol.2012.12.017","article-title":"Chronic kidney disease: mineral and bone disorder in children","volume":"33","author":"Wesseling-Perry","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.bone.2017.01.023_bb0555","article-title":"Effects of cinacalcet on fracture events in patients receiving hemodialysis: The EVOLVE trial","author":"Moe","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"13","key":"10.1016\/j.bone.2017.01.023_bb0560","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jacc.2009.06.017","article-title":"Association of chronic kidney disease with the spectrum of ankle brachial index: The cardiovascular health study","volume":"54","author":"Ix","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bone.2017.01.023_bb0565","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","article-title":"Pathophysiology of vascular calcification in chronic kidney disease","volume":"95","author":"Moe","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2017.01.023_bb0570","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217300236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217300236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T17:20:40Z","timestamp":1568740840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217300236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":114,"alternative-id":["S8756328217300236"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.01.023","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The chronic kidney disease \u2014 Mineral bone disorder (CKD-MBD): Advances in pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}